StonvexLoading…
StonvexStonvexStonvexCore line items from INLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.91M | $16.58M | $12.26M | $8.26M |
Operating Income | $-1.18M | $-1.79M | $-1.57M | $-1.19M |
Net Income | $-1.18M | $-1.87M | $-1.66M | $-1.30M |
EPS (Diluted) | $-0.27 | $-0.44 | $-0.39 | $-0.31 |
Total Assets | $16.46M | $17.31M | $17.99M | $17.16M |
Total Liabilities | $5.99M | $5.92M | $6.55M | $5.59M |
Cash & Equivalents | $2.08M | $2.53M | $3.22M | $2.07M |
Free Cash Flow OCF − CapEx | $-253.40K | $579.49K | $1.13M | $-150.21K |
Shares Outstanding | 4.47M | 4.48M | 4.48M | 4.47M |